FDA BACKS PAPER NDA POLICY

被引：0

|

作者：

不详

机构：

来源：

AMERICAN PHARMACY | 1981年 / 21卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：7 / 8

页数：2

相关论文

共 50 条

[31] ETSI BACKS DOWN ON STANDARDS POLICY
TUTT, N
ELECTRONICS-US, 1994, 67 (18): : 14 - 14
[32] 2004年1～5月FDA批准的药物(NDA)
石奇龙
上海医药, 2004, (07) : 327 - 328
[33] White paper backs small company research plans
不详
PROFESSIONAL ENGINEERING, 2000, 13 (15) : 8 - 8
[34] FDA backs clinician-free AI imaging diagnostic tools
Mark Ratner
Nature Biotechnology, 2018, 36 : 673 - 674
[35] FDA backs clinician-free AI imaging diagnostic tools
Ratner, Mark
NATURE BIOTECHNOLOGY, 2018, 36 (08) : 673 - 674
[36] Government's energy white paper backs renewables
不详
CHEMISTRY IN BRITAIN, 2003, 39 (04) : 12 - 12
[37] Garvey policy backs limits on FOQA data
McKenna, JT
AVIATION WEEK & SPACE TECHNOLOGY, 1998, 149 (23): : 37 - 37
[38] Government & policy - Bush backs tariff removal
Hess, G
CHEMICAL & ENGINEERING NEWS, 2006, 84 (20) : 12 - 12
[39] GelTex NDA for RenaGel non-absorbed phosphate binder accepted as filable by FDA
不详
DIALYSIS & TRANSPLANTATION, 1998, 27 (03) : 130 - +
[40] Policy - EU backs the use of stem cells in research
不详
CHEMISTRY & INDUSTRY, 2001, (19) : 601 - 601

← 1 2 3 4 5 →